Free Trial
CVE:IBT

IBEX Technologies (IBT) Stock Price, News & Analysis

C$1.44 0.00 (0.00%)
As of 04/5/2024

About IBEX Technologies Stock (CVE:IBT)

Key Stats

Today's Range
C$1.44
C$1.44
50-Day Range
C$1.44
C$1.44
52-Week Range
C$0.75
C$1.45
Volume
200 shs
Average Volume
68,888 shs
Market Capitalization
C$35.54 million
P/E Ratio
11.52
Dividend Yield
3.11%
Price Target
N/A
Consensus Rating
N/A

Company Overview

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IBEX Technologies and its competitors with MarketBeat's FREE daily newsletter.

IBT Stock News Headlines

[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.
ibex Launches Wave iX Translate
IBEX Completes Sale of the Company
IBEX Technologies Inc.
See More Headlines

IBT Stock Analysis - Frequently Asked Questions

IBEX Technologies' stock was trading at C$1.44 at the beginning of 2025. Since then, IBT shares have increased by 0.0% and is now trading at C$1.44.
View the best growth stocks for 2025 here
.

Shares of IBT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that IBEX Technologies investors own include Aurora Cannabis (ACB), Acerus Pharmaceuticals (TRLPF), Air Canada (AC), American Airlines Group (AAL), Cognex (CGNX), Baytex Energy (BTE) and Bank of Montreal (BMO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:IBT
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
11.52
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$3.10 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$5.77 million
Cash Flow
C$0.92 per share
Price / Cash Flow
1.56
Book Value
C$0.58 per share
Price / Book
2.48

Miscellaneous

Free Float
N/A
Market Cap
C$35.54 million
Optionable
Not Optionable
Beta
-0.05
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (CVE:IBT) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners